We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cetuximab + Gemox in Biliary Tract Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01216345
First Posted: October 7, 2010
Last Update Posted: October 7, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Association of Research on the Biology of Liver Tumors
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Publications:
Gruenberger B, Schueller J, et al: K-ras status and response in patients with advanced or metastatic cholangiocarcinoma treated with cetuximab plus gemcitabine-oxaliplatin (GEMOX): a single center phase II study J Clin Oncol 27:15s, 2009 (suppl; abstr 4586)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

To Top